Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath

S. Anirban (Amsterdam, Netherlands)

Source: ERS Lung Science Conference 2016
Number: 22
Disease area: Airway diseases

PDF journal article, handout or slidesSlide presentationWebcastMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Anirban (Amsterdam, Netherlands). Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath. ERS Lung Science Conference 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008


The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma
Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases
Year: 2010

Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate
Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation
Year: 2008


Markers of airway diseases in exhaled breath condensate and their clinical value
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013


Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: Suppl. 50, 747s
Year: 2006

Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes.
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017


Alcohol metabolites are detectable in exhaled breath of healthy, unaffected by a breath holding maneuver and may serve as novel pro-inflammatory biomarkers in asthma and COPD
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008

Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010


Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 412s
Year: 2002

Metabonomics applied to exhaled breath condensate in childhood asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 123s
Year: 2006

Inflammatory markers in exhaled breath condensate of two COPD phenotypes
Source: Eur Respir J 2005; 26: Suppl. 49, 260s
Year: 2005

Relationship of inflamamatory markers in blood and exhaled breath condensate in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 283s
Year: 2006

Exhaled breath molecular profiling in measuring inflammatory status in COPD
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008


Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008



Exhaled breath condensate eicosanoids as markers of asthma severity
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008